• No results found

[PDF] Top 20 Central Pain in Parkinson’s Disease: A Case Report

Has 10000 "Central Pain in Parkinson’s Disease: A Case Report" found on our website. Below are the top 20 most common "Central Pain in Parkinson’s Disease: A Case Report".

Central Pain in Parkinson’s Disease: A Case Report

Central Pain in Parkinson’s Disease: A Case Report

... His pain only mildly responded to NSAID ...burning pain in his right upper and lower extremity was decreased by the next clinic visit, and he was main- tained on the same dosing schedule for one ...his ... See full document

9

Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson’s disease: a case report

Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson’s disease: a case report

... Parkinson’s disease (Hoehn & Yahr stage 1) accord- ing to the UK Parkinson’s Disease Society Brain Bank cri- teria ...contact case; cathode, contacts ...contacts case; cathode, contact ... See full document

5

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson's disease: a case report

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson's disease: a case report

... we report our longitudinal findings in one PD patient, ie, decreases in striatal dopamine transporter binding during one year of follow-up after unilateral DBS at the subthalamic ...this case, we ... See full document

5

Possible treatment for the Pisa-syndrome by Parkinson disease: a case report

Possible treatment for the Pisa-syndrome by Parkinson disease: a case report

... One case can never be an significant prove that this approach is working but it has learn us that the shortening of the spine ( Pisa – Syndrome) has his roots in an malfunction in the ...every Parkinson ... See full document

25

Amino acid management of Parkinson’s disease: a case study

Amino acid management of Parkinson’s disease: a case study

... leg pain, ataxia, falling, gait abnormalities, blepharospasm (which may be taken as an early sign of excess dosage), trismus, increased tremor, numbness, muscle twitching, peripheral neuropathy, myocardial ... See full document

10

<p>Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease</p>

<p>Validation study of the Parkinson&rsquo;s Fatigue Scale in advanced Parkinson&rsquo;s disease</p>

... ’ s Parkinsons Disease Pain scale; and grant from the International Parkinson and Movement Disorder Society to attend the congress of the society in ...authors report ... See full document

12

&lt;p&gt;Femoral mononeuropathy in Lyme disease: a case report&lt;/p&gt;

<p>Femoral mononeuropathy in Lyme disease: a case report</p>

... the central part fades, creating a ring-like appearance or a “ bull ’ s ...this disease, setting aside the standard assays and testing algorithms used in a university or specialty ...the ... See full document

5

Rasagiline in treatment of Parkinson&amp;rsquo;s disease

Rasagiline in treatment of Parkinson&rsquo;s disease

... The combination of non-selective MAOIs (such as the anti- depressant medications tranylcypramine and phenelzine) and specifi c serotonin reuptake inhibitors (SSRIs) carries a risk of causing the serotonergic syndrome ... See full document

10

Stabilometric analysis in individuals with parkinson`s disease

Stabilometric analysis in individuals with parkinson`s disease

... unexpected falls in PD patients (Marchese et al., 2003). These falls cause devastating consequences and are accompanied by pain, reduced mobility and unacceptably high levels of caregiver stress. Fear of falling ... See full document

6

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson&amp;rsquo;s disease

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson&rsquo;s disease

... Patients were instructed on the potential side effects of tapentadol ER and, at each visit, they were asked whether they had experienced any gastrointestinal side effects such as nausea, vomiting, and constipation, ... See full document

8

Botulinum toxin for drooling in Parkinson s disease

Botulinum toxin for drooling in Parkinson s disease

... neurone disease supported this in- tervention in this population (Young ...studies, case series, and controlled clinical trials performed since these early studies have documented varying efficacy of BoNT ... See full document

17

&lt;p&gt;Sleep disturbances in Parkinson&amp;rsquo;s disease are associated with central parkinsonian pain&lt;/p&gt;

<p>Sleep disturbances in Parkinson&rsquo;s disease are associated with central parkinsonian pain</p>

... at disease onset was 60 years (sd=12), and mean duration of the disease was 9 years ...scale S&E were 75 (sd=17) in off and 87 (sd=11) in ...reported pain. Of those with pain, 99 ... See full document

8

Pain management in patients with Parkinson&amp;#39;s disease: challenges and solutions

Pain management in patients with Parkinson&#39;s disease: challenges and solutions

... of Parkinson-related pain which is one of the more frequently reported nonmotor symptoms in Parkinson’s disease (PD), which is the second most common neurodegenerative disease after ... See full document

11

Review: management of Parkinson&amp;#39;s disease

Review: management of Parkinson&#39;s disease

... Parkinson’s disease (PD) is one of the most frequent neurological ...the disease management often complicated even when the presence of PD seems ...the disease, especially with the progressive effect ... See full document

20

A review of pulmonary function in Parkinson&amp;rsquo;s disease

A review of pulmonary function in Parkinson&rsquo;s disease

... Hoehn and Yahr stage was II–V for the PD group and the MSA group comprised 20 probable and 7 possible MSA. Spirometry showed a restrictive pattern in 56.7% of PD patients (63% MSA), central obstructive in 3.3% PD ... See full document

11

Sleep disorders in Parkinson&amp;rsquo;s disease

Sleep disorders in Parkinson&rsquo;s disease

... that sleepiness is common in PD and may be associated with the disease itself, or caused by sleep disorders or medications. Because EDS and somnolence may occur during the initial titration of dopaminergic ... See full document

6

Spotlight on olfactory dysfunction in Parkinson&amp;#39;s disease

Spotlight on olfactory dysfunction in Parkinson&#39;s disease

... the disease has been ...faster disease progression and higher risk of cognitive decline in patients with ...Parkinson’s disease, olfaction, smell identification test, ... See full document

9

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

... augmented disease in which spasticity was observed on days 16 and 17 ( P = ...clinical disease as we have reported previously ...of disease with a mean day of onset ... See full document

13

A case report of central toxic keratopathy in a patient post TransPRK  (followed by corneal collagen cross-linking)

A case report of central toxic keratopathy in a patient post TransPRK (followed by corneal collagen cross-linking)

... progressive central anterior stromal opacity formation only in the left eye were ...with central corneal thinning in the anterior stroma. A central anterior stromal dense opacity had formed in the ... See full document

8

&lt;p&gt;Association between &lt;em&gt;ADORA2A&lt;/em&gt; gene polymorphisms and schizophrenia in the North Chinese Han population&lt;/p&gt;

<p>Association between <em>ADORA2A</em> gene polymorphisms and schizophrenia in the North Chinese Han population</p>

... HCl (pH 8.3), 500 mM KCl, 15 mM MgCl2 and Taq (0.725 U; Takara, China, DaLian). PCR was performed in a Techne DNA Thermal Cycler (Biometra, ABI, USA) with 5 min of denaturation at 94 °C followed by 30 cycles with ... See full document

8

Show all 10000 documents...